| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |